Liliana Ethel Favaloro

Liliana Ethel Favaloro

Auto-generated profile, based on publicly available information

Liliana Ethel Favaloro

Presidencia Fundación Favaloro, Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in The American Journal of Cardiology
Verified
Journal Article
Closed access
AFAdrián Fernández
Adrián Fernández
AQAlejandro Quiroga
Alejandro Quiroga
JOJuan Pablo Ochoa
Juan Pablo Ochoa
MMMauricio Mysuta
Mauricio Mysuta
JCJosé Horacio Casabé
José Horacio Casabé
NGNéstor Galizio
Néstor Galizio

6 July 2012 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
LFLiliana Favaloro
Liliana Favaloro
MDMirta Diez
Mirta Diez
OMOscar Mendiz
Oscar Mendiz
GJGustavo Vera Janavel
Gustavo Vera Janavel
LVLeón Valdivieso
León Valdivieso
ACAlberto Crottogini
Alberto Crottogini

4 October 2011 in Cardiology
Verified
Journal Article
Open access
PDF file
RLRubén Laguens
Rubén Laguens
PAPaulino A. Alvarez
Paulino A. Alvarez
CVCarlos Vigliano
Carlos Vigliano
PMPatricia Cabeza Meckert
Patricia Cabeza Meckert
LFLiliana Favaloro
Liliana Favaloro
RFRoberto Favaloro
Roberto Favaloro
Background: In patients with idiopathic dilated cardiomyopathy (IDCM), the myocardial blood flow is markedly depressed. The presence of alterations in the number and length of the coronary microcirculation has not been explored. Methods: In explanted hearts of 6 patients with IDCM and in 6 normal control hearts, the arteriolar length density and capillary numerical density were determined in sections stained with orcein (vessels 50–200 µm in diameter), for smooth muscle actin (vessels 6–50 µm in diameter) and CD34 (capillaries). Results: No difference with normal hearts was observed in capillary numerical density and in length density of vessels above 50 µm in diameter. In IDCM, more than 50% of arterioles below 50 µm in diameter displayed an incomplete smooth muscle wall, and length density, especially for arterioles between 6 and 20 µm in diameter, was significantly lower (42.84 ± 8.51 mm/mm3) than in controls (75.34 ± 3.05 mm/mm3, p = 0.001). Conclusions: In IDCM, arterioles below 50 µm in diameter display an incomplete smooth muscle wall and a significant decrease in length density. These observations provide an anatomical basis for a decreased coronary flow reserve in IDCM.

1 July 2004 in Transplantation Proceedings
Verified
Journal Article
Closed access
RFR. Favaloro
R. Favaloro
MDM. Diez
M. Diez
ABA. Bertolotti
A. Bertolotti
CGCarmen Gómez Gómez
Carmen Gómez Gómez
LFL. Favaloro
L. Favaloro
SPS. Perrone
S. Perrone

1 January 2010 in Transplantation Proceedings
Verified
Journal Article
Closed access
RFR. Favaloro
R. Favaloro
MPM. Peradejordi
M. Peradejordi
ABA. Bertolotti
A. Bertolotti
MDM. Diez
M. Diez
LFL. Favaloro
L. Favaloro
SMS. Moscoloni
S. Moscoloni

1 August 2021 in Current Hypertension Reviews
Verified
Journal Article
Closed access
PDF file
LFLiliana E. Favaloro
Liliana E. Favaloro
RRRoxana D. Ratto
Roxana D. Ratto
CMCarla Musso
Carla Musso
: The relationship between diabetes and risk of heart failure has been described in previous trials, releasing the importance of the hyperglycemic state that, added to other risk factors, favors the development of coronary heart disease. The mechanism by which, in the absence of hypertension, obesity and/or dyslipidemia, diabetic patients develop cardiomyopathy has been less studied. : Recently, the Sodium Glucose Co-transporter type 2 inhibitors (SGLT2 inhibitors) used for the treatment of heart failure patients with or without diabetes has been a breakthrough in the field of medicine. : This review describes the established pathophysiology of diabetic cardiomyopathy and SGLT2 inhibitors, their mechanisms of action, and benefits in this group of patients.